Gene · 5957
Papers1,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Indications and Diagnostic Yield of Paraneoplastic and Autoimmune Encephalitis Antibody Testing: A Retrospective Cohort Study. | Brain Behav | 2025 | 40847447 | PubTator, text mining | PubMed |
| Non-genetic neuromodulation with graphene optoelectronic actuators for disease models, stem cell maturation, and biohybrid robotics. | Nat Commun | 2025 | 40835596 | PubTator, text mining | PubMed |
| Diagnosis and treatment of autoimmune retinopathy: review of current approaches. | Int Ophthalmol | 2025 | 40824502 | PubTator, text mining | PubMed |
| Analyzing Photoreceptor Degeneration and Preservation in a Retinitis Pigmentosa Murine Model. | J Vis Exp | 2025 | 40788905 | PubTator, text mining | PubMed |
| Efficacy of early rituximab treatment in anti-mGluR1 encephalitis: a case report. | BMC Neurol | 2025 | 40760473 | PubTator, text mining | PubMed |
| Social anxiety disorder and antibodies against glial cells in the cerebrospinal fluid. | Brain Behav Immun Health | 2025 | 40746968 | PubTator, text mining | PubMed |
| Diagnostic Significance of Paraneoplastic Neuronal Antibodies in Japanese Adults with Autoimmune Encephalitis: A Case Series Study in an Adult Epilepsy Clinic. | Clin Pharmacol | 2025 | 40620335 | PubTator, text mining | PubMed |
| A comparative study of the effectivity of MSC-based, NP-based and combined therapies in an experimental model of NaIO3-induced retinal degeneration. | Sci Rep | 2025 | 40594667 | PubTator, text mining | PubMed |
| Identification of novel causally related genes in adenomyosis: An integrated summary data-based Mendelian randomization study and bioinformatics analysis. | Medicine (Baltimore) | 2025 | 40527793 | PubTator, text mining | PubMed |
| Gamma-aminobutiric acid-B receptor antibody-related limbic encephalitis due to small cell lung carcinoma: Two case reports. | World J Clin Cases | 2025 | 40487548 | PubTator, text mining | PubMed |
| Clinical Outcome of Immunosuppressive Therapy in Autoimmune Retinopathy. | Ocul Immunol Inflamm | 2025 | 40327356 | PubTator, text mining | PubMed |
| Hierarchical contrastive learning for multi-label text classification. | Sci Rep | 2025 | 40269091 | PubTator, text mining | PubMed |
| Theoretical Basis for Refractive Index Changes Resulting from Solution Phase Molecular Interaction. | J Phys Chem B | 2025 | 40130812 | PubTator, text mining | PubMed |
| Enigmatic intractable Epilepsy patients have antibodies that bind glutamate receptor peptides, kill neurons, damage the brain, and cause Generalized Tonic Clonic Seizures. | J Neural Transm (Vienna) | 2025 | 39932550 | PubTator, text mining | PubMed |
| Phospho-seq: integrated, multi-modal profiling of intracellular protein dynamics in single cells. | Nat Commun | 2025 | 39905064 | PubTator, text mining | PubMed |
| Before Diagnosing DPHL, All Differential Diagnoses Must Be Thoroughly Ruled Out. | Intern Med | 2025 | 39496451 | PubTator, text mining | PubMed |
| Non-progressive CRMP-5-Associated Perifoveal Retinopathy in a Breast Cancer Patient: A Rare Paraneoplastic Phenomenon. | Cureus | 2024 | 39720375 | PubTator, text mining | PubMed |
| Long term survival and outcomes in patients with paraneoplastic neurologic syndromes. | Front Immunol | 2024 | 39624101 | PubTator, text mining | PubMed |
| Rapidly progressive central retinal pigmented epithelium atrophy after Ivospemin (SBP-101) treatment for pancreatic adenocarcinoma. | Am J Ophthalmol Case Rep | 2024 | 39502458 | PubTator, text mining | PubMed |
| Genetically Engineered Liposwitch-Based Nanomaterials. | Biomacromolecules | 2024 | 39495202 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5957/papers?page=2